ESC 365 - De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

ESC Premium Access

De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

Session: Advances in Chronic Thromboembolic Pulmonary Hypertension

Topic: Pulmonary Hypertension

Speaker: Doctor M. Kimura (Tokyo, JP)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Mai Kimura

Keio University Hospital, Tokyo (Japan)

0 follower

2 more presentations in this session

Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study)

Speaker: Doctor E. Klok (Leiden, NL)

Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects

Speaker: Mrs F. Petit Dop (Suresnes, FR)

Access the full session

Advances in Chronic Thromboembolic Pulmonary Hypertension

Speakers: Doctor M. Kimura, Doctor E. Klok, Mrs F. Petit Dop

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by